Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Hiroshi Matsuoka
Institution:
Fujita Health University
Observed institution:
Fujita Health University
ORCID:
0000-0002-7837-565X
Observed ORCID:
0000-0002-7837-565X
OpenAlex ID:
A5133058803
Incidence and clinical characteristics of zolbetuximab-induced nausea and vomiting in CLDN18.2-positive unresectable advanced or recurrent gastric cancer: a retrospective study
2026
·
Yosuke Ando
, Hiroki Banno
, et al.
·
Journal of Pharmaceutical Health Care and Sciences
·
1
Correction: An observational study of the effectiveness and safety of nivolumab plus chemotherapy for untreated advanced or recurrent gastric cancer in Japanese real-world settings: the G-KNIGHT study
2026
·
Shigenori Kadowaki
, Tomoyuki Otsuka
, et al.
·
Gastric Cancer
PDF
Clinical Impact of Baseline ctDNA RAS/BRAF Mutations on Conversion Surgery and Outcomes in First-Line Anti-EGFR Therapy for Advanced Colorectal Cancer
2026
·
Takeshi Yamada
, Takeshi Nagasaka
, et al.
·
Cancers
Functional Analysis of DPYD Variants Associated With 5‐Fluorouracil‐Based Anticancer Drug Toxicity in Cancer Patients
2026
·
Yuta Sudo
, Yoko Nakajima
, et al.
·
Journal of Clinical Pharmacy and Therapeutics
Show more works
View as search
Works count:
4
Citation count:
1
H-index:
1
I10-index:
Year
Topic
Type